{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-045850","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.877371+00:00","generated_at":"2026-05-22T05:21:32.405285+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Liquidia Q1 net loss $38.4M ($0.45/sh); PDUFA May 24; court dismisses UTHR cross-claim","bullets":["Net loss of $38.4M ($0.45 per share) vs $30.1M ($0.40) prior year; cash $169.8M.","Revenue $3.1M from Sandoz promotion agreement; R&D down 31% as shift to commercialization.","PDUFA goal date May 24, 2025 for YUTREPIA NDA; FDA accepted Class 1 resubmission.","District Court dismissed UTHR cross-claim challenging PH-ILD amendment; UTHR may appeal.","Amended HCR agreement provides up to $100M additional financing for commercial launch."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-045850","json":"https://secwatch.observer/filing/0001104659-25-045850.json","markdown":"https://secwatch.observer/filing/0001104659-25-045850.md","text":"https://secwatch.observer/filing/0001104659-25-045850.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925045850/0001104659-25-045850-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925045850/tm2514389d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T05:21:32.405285+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}